Pediatric Pulmonary University of Colorado Medical School and The Children's Hospital
Pediatric Pulmonology
Dr. Jeffrey S. Wagener, MD
|
|
Give Review
Jeffrey Wagener is an expert in the field of Pediatric Pulmonology. He researched medicine at University of Colorado Denver School of Medicine. University of Colorado Denver School of Medicine is one of the top medical schools in the US. University of Colorado Denver School of Medicine is ranked 35 in research and 8 in primary care medicine Doctor Jeffrey S. Wagener, MD is a published physician. He has 87 papers published. The most current publication "Aerosol delivery and safety of recombinant human deoxyribonuclease in young children with cystic fibrosis: a bronchoscopic study. Pulmozyme Pediatric Broncoscopy Study..."
Publications
- Measuring Generic Health-Related Quality Of Life And Impact Of Health Resource Utilization In Adults With Cystic Fibrosis.
- Clinical and Economic Burden of Pulmonary Excerbations In Patients With Cystic Fibrosis Who are Homozygous For The F508del Mutation.
- Inpatient Burden Among Patients With Cystic Fibrosis Who Are Homozygous for The F508del Mutation.
- Pulmonary function outcomes for assessing Cystic fibrosis care.
- Liver Involvement in the Hispanic Cystic Fibrosis Population of North America.
- Pulmonary capillaritis in monozygotic twin boys.
- Clinical use of tobramycin inhalation solution (TOBI®) shows sustained improvement in FEV1 in Cystic fibrosis.
- Oral, inhaled, and intravenous antibiotic choice for treating pulmonary exacerbations in Cystic fibrosis.
- Pulmonary exacerbations in Cystic fibrosis: young children with characteristic signs and symptoms.
- Probability of Treatment Following Acute Decline in Lung Function in Children with Cystic Fibrosis is Related to Baseline Pulmonary Function.
- Dornase alfa (Pulmozyme).
- Chronic airway obstruction in children: evaluation with cine-CT.
- Acute viral laryngotracheitis complicated by herpes simplex virus infection.
- The Staphylococcus aureus lipoprotein SitC colocalizes with Toll-like receptor 2 (TLR2) in murine keratinocytes and elicits intracellular TLR2 accumulation.
- Chronic aspiration pneumonitis.
- Abnormalities in control of ventilation in newborn infants with myelomeningocele.
- Lung biopsy in immunocompromised children: when, how, and who?
- Managing acute pediatric asthma: keeping it short.
- Large airway collapse in bronchoPulmonary dysplasia.
- Pulmonary mechanics in healthy term neonates: variability in measurements obtained with a computerized system.
- Intra-subject variability of noninvasive oxygen measurements.
- On follicular bronchitis/bronchiolitis without bronchiectasis.
- Fatality following fiberoptic bronchoscopy in a two-year-old child.
- Fatal prolonged foreign body aspiration following an asymptomatic interval.
- Parainfluenza type II infection in dogs. A model for viral lower Respiratory tract infection in humans.
- Role of canine parainfluenza virus and Bordetella bronchiseptica in kennel cough.
- Inhaled steroids in children: risks versus rewards.
- Management of children hospitalized for laryngotracheobronchitis.
- Ferrokinetic and hematologic studies in Cystic fibrosis patients.
- Unusual abnormalities in adolescent siblings with alpha 1-antitrypsin deficiency.
- Cystic fibrosis study questioned.
- Pulmonary function in juvenile rheumatoid arthritis.
- Anti-inflammatory therapy for children with asthma.
- Safety and preliminary clinical activity of a novel pancreatic enzyme preparation in pancreatic insufficient Cystic fibrosis patients.
- Bronchoscopy with bronchoalveolar lavage in the evaluation of Pulmonary complications of bone marrow transplantation in children.
- The diagnostic value of bronchoalveolar lavage in immunocompetent children with chronic diffuse Pulmonary infiltrates.
- Factor II (prothrombin) coagulant activity in immunoreactive protein: detection of vitamin K deficiency and liver disease in patients with Cystic fibrosis.
- A debate on why my state (province) should or should not conduct newborn screening for Cystic fibrosis (14th Annual North American Cystic Fibrosis Conference).
- Early inflammation and the development of pulmonary disease in Cystic fibrosis.
- Laparoscopic fundoplication to enhance Pulmonary function in children with severe reactive airway disease and gastroesophageal reflux disease.
- Location and duration of treatment of Cystic fibrosis respiratory exacerbations.
- Ultrase MT12 and Ultrase MT20 in the treatment of exocrine pancreatic insufficiency in Cystic fibrosis: safety and efficacy.
- Diagnostic accuracy of oropharyngeal cultures in infants and young children with Cystic fibrosis.
- A comparison of the efficacy and tolerance of pancrelipase and placebo in the treatment of steatorrhea in Cystic fibrosis patients with clinical exocrine pancreatic in...
- Short-term effects of postural drainage with clapping vs autogenic drainage on oxygen saturation and sputum recovery in patients with Cystic fibrosis.
- Relationship of genotype to early pulmonary function in infants with Cystic fibrosis identified through neonatal screening.
- Randomized, double-blind, placebo-controlled, dose-escalating study of aerosolized interferon gamma-1b in patients with mild to moderate Cystic fibrosis lung disease.
- Beclomethasone diproprionate reduced airway inflammation without adrenal suppression in young children with Cystic fibrosis: a pilot study.
- Prospective, long-term study of fat-soluble vitamin status in children with Cystic fibrosis identified by newborn screen.
- Aerosol delivery and safety of recombinant human deoxyribonuclease in young children with Cystic fibrosis: a bronchoscopic study. Pulmozyme Pediatric Broncoscopy Study...
- Increased DNA levels in bronchoalveolar lavage fluid obtained from infants with Cystic fibrosis.
- Early pulmonary inflammation in infants with Cystic fibrosis.
- Design and powering of Cystic fibrosis clinical trials using rate of FEV(1) decline as an efficacy endpoint.
- Risk factors for initial acquisition of Pseudomonas aeruginosa in children with Cystic fibrosis identified by newborn screening.
- Significant microbiological effect of inhaled tobramycin in young children with Cystic fibrosis.
- Lung function decline from adolescence to young adulthood in Cystic fibrosis.
- Socioeconomic status and the likelihood of antibiotic treatment for signs and symptoms of pulmonary exacerbation in children with Cystic fibrosis.
- Clinical use of dornase alpha is associated with a slower rate of FEV1 decline in Cystic fibrosis.
- Comparative effectiveness of Pleural drainage procedures for the treatment of complicated pneumonia in childhood.
- Longitudinal assessment of health-related quality of life in an observational cohort of patients with Cystic fibrosis.
- Trends in the use of routine therapies in Cystic fibrosis: 1995-2005.
- Pulmonary outcome prediction (POP) tools for Cystic fibrosis patients.
- Impact of pregnancy on women with Cystic fibrosis.
- Two-tiered immunoreactive trypsinogen-based newborn screening for Cystic fibrosis in Colorado: screening efficacy and diagnostic outcomes.
- Complications associated with symptomatic diagnosis in infants with Cystic fibrosis.
- Compacted DNA nanoparticles administered to the nasal mucosa of Cystic fibrosis subjects are safe and demonstrate partial to complete Cystic fibrosis transmembrane reg...
- Late diagnosis defines a unique population of long-term survivors of Cystic fibrosis.
- Induced sputum inflammatory measures correlate with lung function in children with Cystic fibrosis.
- Update on newborn screening for Cystic fibrosis.
- Myeloperoxidase and protein oxidation in the airways of young children with Cystic fibrosis.
- Growth and nutritional indexes in early life predict pulmonary function in Cystic fibrosis.
- Cystic fibrosis: current trends in respiratory care.
- Year-to-year changes in lung function in individuals with Cystic fibrosis.
- Impact of socioeconomic status, race, and ethnicity on quality of life in patients with Cystic fibrosis in the United States.
- Association of socioeconomic status with the use of chronic therapies and healthcare utilization in children with Cystic fibrosis.
- Characterizing aggressiveness and predicting future progression of CF lung disease.
- The impact of incident methicillin resistant Staphylococcus aureus detection on pulmonary function in Cystic fibrosis.
- Impact of Pseudomonas and Staphylococcus infection on inflammation and clinical status in young children with Cystic fibrosis.
- Relationship between inhaled corticosteroid therapy and rate of lung function decline in children with Cystic fibrosis.
- Shifting patterns of inhaled antibiotic use in Cystic fibrosis.
- Trends in the clinical characteristics of the U.S. Cystic fibrosis patient population from 1995 to 2005.
- Decreased total serum coenzyme-Q10 concentrations: a longitudinal study in children with Cystic fibrosis.
- Risk factors for rate of decline in forced expiratory volume in one second in children and adolescents with Cystic fibrosis.
- A pilot study on the safety and efficacy of a novel antioxidant rich formulation in patients with Cystic fibrosis.
- Presence of methicillin resistant Staphylococcus aureus in respiratory cultures from Cystic fibrosis patients is associated with lower lung function.
- Infant care patterns at epidemiologic study of Cystic fibrosis sites that achieve superior childhood lung function.
Schools
University Of Colorado Denver School Of Medicine
University Of Washington Program
University Of Arizona Program
Procedures Preformed
- Ventilation Management
Conditions Treated
- Atelectasis
- Cystic Fibrosis
- Pleural Effusion
- Pneumonia
- View All
Doctors Specialties
- Pediatric Critical Care Medicine
- Pediatric Pulmonology
Accepted Insurances
Education
-
University of Arizona -
University of Washington -
University of Colorado Denver School of Medicine
Hospital
-
Children's Hospital Colorado -
University of Colorado Hospital
Helpful Reviews
Similar Doctors
|
Dr. James E. Shira, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Paul C. Stillwell, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Angela S. Czaja, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Vivek Balasubramaniam, MD |
|
Dr. Carleen A. Zebuhr, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Margarita Guarin, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Robin R. Deterding, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. James T. Olin, MD |
|
|
Dr. Joseph A. Albietz III, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Eva N. Grayck, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Anne-Laure Martin, MD |
|
|
Dr. Krista Kohl, PHD |
|
|
Dr. Edith T. Zemanick, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Gwendolyn S. Kerby, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Heather D. Hack, FNP |
|
|
Heather E. Hoch
This Doctor is OpenDoctor Recommended.
|